Treatment Resulting Changes in Volumes of High-(18)F-FDG-Uptake Adipose Tissues over Orbit and Epicardium Correlate with Treatment Response for Non-Hodgkin’s Lymphoma

Background: A regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment for non-Hodgkin’s lymphoma. Brown adipose tissue possesses anti-cancer potential. This study aimed to explore practical biomarkers for non-Hodgkin’s lymphoma by analyzing...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Ming, Hsieh, Chen-Hsi, Wang, Shan-Ying, Tsao, Chin-Ho, Lee, Jehn-Chuan, Chen, Yu-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916748/
https://www.ncbi.nlm.nih.gov/pubmed/36768479
http://dx.doi.org/10.3390/ijms24032158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916748/
https://www.ncbi.nlm.nih.gov/pubmed/36768479
http://dx.doi.org/10.3390/ijms24032158

Ejemplares similares